Consistent with these reports, serum SAP levels decreased significantly with the progression of liver fibrosis in both patients with chronic hepatitis B and patients with NAFLD (S4A and S4B Fig). Here, APCS is linked to metabolic dysfunction-associated steatotic liver disease.